Actively Recruiting

Age: 18Years +
All Genders
Healthy Volunteers
NCT07368647

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Led by Rachel A. Moses · Updated on 2026-01-26

100

Participants Needed

1

Research Sites

295 weeks

Total Duration

On this page

Sponsors

R

Rachel A. Moses

Lead Sponsor

D

Dartmouth-Hitchcock Medical Center

Collaborating Sponsor

AI-Summary

What this Trial Is About

Collection of urine, blood, and tissue samples from patients undergoing hyperbaric oxygen therapy

CONDITIONS

Official Title

Chronic Radiation Cystitis and Effect of Hyperbaric Oxygen Therapy on Patient Reported Outcomes and Urine Inflammatory Biomarkers

Who Can Participate

Age: 18Years +
All Genders
Healthy Volunteers

Eligibility Criteria

Eligible

You may qualify if you...

  • At least 18 years of age
  • For Cohort 1: Post pelvic radiation with moderate to severe radiation cystitis and recurrent visible blood in urine without infection or cancer, confirmed by specialists and tests
  • Scheduled to start or have started HBOT within the past 7 days as standard care for radiation cystitis (Cohort 1)
  • At least 18 years of age without history of pelvic radiation and scheduled to start or have started HBOT within past 7 days for reasons other than bladder inflammation (Cohort 2)
  • At least 18 years of age without history of pelvic radiation or HBOT (Cohort 3)
  • At least 18 years of age similar to Cohort 1 but opting out of HBO therapy (Cohort 4)
Not Eligible

You will not qualify if you...

  • Pregnant or lactating females
  • Uncompensated heart failure, fluid overload, or recent myocardial infarction preventing HBOT
  • History of uncontrolled seizure disorder, active urinary tract infection, active Grave's disease, cystic fibrosis, sickle cell anemia, known HIV, or autoimmune disease needing active steroid or immunomodulating treatment
  • Refusal to sign informed consent
  • Prior participation in clinical trials affecting immune status

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Dartmouth-Hitchcock Medical Center

Lebanon, New Hampshire, United States, 03756

Actively Recruiting

Loading map...

Research Team

R

Rachel Moses, MD

CONTACT

A

Amanda Wittemann

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

4

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here